15 January, 2019Comments are off for this post.

Aortyx at Biotech Showcase 2019 (37th JP Morgan Healthcare Conference)

The JP Morgan Healthcare conference is the most important networking event for biotech and medtech companies. Started in 2008, the event, held at the Hilton San Francisco Union Square, brings more than 3,500 decision makers from more than 2,000 biotech, financial, and pharma companies to network and share insights on industry trends through plenary sessions, fireside chats, and panels.

Aortyx was present, thanks to the support of FIPSE’s International Acceleration Program, to interact with a number of stakeholders. Dr. Jordi Martorell attended to more than 30 meetings in 3 exciting days with investors, business developers, clinical manufacturing organizations and clinical research organizations. As a result, the roadmap from prototype to market was polished and adapted to the highest standards and the team was ready to start the Seed Round.

1 November, 2018Comments are off for this post.


Aortyx - team

Aortyx was founded in October 2018. Co-founders are Dr. Jordi Martorell, Ms. Noemí Balà, Dr. Vicenç Riambau and Dr. Salvador Borrós. Aortyx aims at bringing hope to aortic diseases patients by delivering novel therapies that change their lives.


The ultimate solution for aortic diseases

The ultimate solution for aortic diseases

The ultimate solution for aortic diseases

© 2019. AORTYX.